The bill amends various sections of the Minnesota Statutes to update the regulatory framework surrounding medical cannabis and hemp products. A significant change is the replacement of the term "commissioner" with "office," indicating a shift in oversight responsibilities to the Office of Cannabis Management. The bill redefines key terms such as "health care practitioner," "medical cannabis manufacturer," and "patient registry number," aligning them with the new administrative structure. It also introduces new requirements for health care practitioners, including the obligation to inform patients about the risks and benefits of medical cannabis, and establishes penalties for the intentional diversion of cannabis outside the state, as well as protections for patient data.

Additionally, the bill outlines operational guidelines for cannabis microbusinesses and manufacturers, including the introduction of a cannabis microbusiness license and updated provisions for product testing and labeling. It mandates that businesses disclose information about pesticides and contaminants, and specifies detailed labeling requirements for cannabis and hemp-derived products. The amendments aim to enhance regulatory clarity, ensure consumer safety, and promote equitable practices within the cannabis industry in Minnesota, while also streamlining the legal framework governing these products.

Statutes affected:
Introduction: 152.22, 152.24, 152.25, 152.26, 152.261, 152.27, 152.28, 152.29, 152.31, 152.32, 152.33, 152.35, 152.37, 342.01, 342.02, 342.12, 342.14, 342.151, 342.22, 342.28, 342.29, 342.30, 342.33, 342.44, 342.46, 342.52, 342.57, 342.59, 342.61, 342.63